SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-23-001572
Filing Date
2023-01-17
Accepted
2023-01-17 12:51:31
Documents
2
Period of Report
2023-01-05

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1595
2 ex24.htm EX-24 9104
  Complete submission text file 0001493152-23-001572.txt   12093
Mailing Address 13631 PROGRESS BLVD. ALACHUA FL 32615
Business Address
Freitag Gregory Gene (Reporting) CIK: 0001492710 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41184 | Film No.: 23530985

Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Issuer) CIK: 0001859007 (see all company filings)

IRS No.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations